Combination therapy with anti-PD1 or anti-CTLA4

Drug Discovery & Development In vivo models Combination therapy with anti-PD1 or anti-CTLA4

Service description

This type of therapy allows the targeting of mechanisms or pathways that have an important role in the development of cancers. In vivo tests provide a means of evaluating the effectiveness of these PD1 or CTLA4 therapies. Tumor cells are injected subcutaneously. When the size of the tumor is reached, antibody injections and tumour progression allow the effectiveness of the treatment to be monitored.

Materials to provide

• Samples
Further details on the project may be requested directly by the expert. You will be able to exchange directly with the experts after filling in the form below.

Delivrable(s)

  • Study following the specifications validated with the Expert

Your project

Please answer all questions below to specify your requirements